18:48:27 EDT Wed 24 Apr 2024
Enter Symbol
or Name
USA
CA



Imagin Medical Inc
Symbol IME
Shares Issued 39,772,634
Close 2016-09-21 C$ 0.105
Market Cap C$ 4,176,127
Recent Sedar Documents

Imagin appoints Messing to scientific advisory board

2016-09-22 09:16 ET - News Release

Mr. Jim Hutchens reports

DR. EDWARD MESSING, CHIEF OF UROLOGY, U ROCHESTER MEDICAL CENTER JOINS IMAGIN MEDICAL'S SCIENTIFIC BOARD OF ADVISORS

Imagin Medical Inc. has provided the following update. Dr. Edward Messing, chair of urology, University of Rochester Medical Center, has joined Imagin's scientific board of advisers.

Dr. Messing is a renowned expert in the diagnosis and treatment of cancers of the bladder, prostate, kidney and other genitourinary organs. He has conducted extensive research in the basic biology of bladder and prostate cancers, and has been the principal investigator on numerous clinical studies for the detection, prevention and treatment of genitourinary cancers. Dr. Messing received his MD degree from New York University, performed his surgery training at NYU-Bellevue Hospital and completed his urology residency at Stanford University. He was director of the urologic oncology program at the University of Wisconsin, and assumed his current position at the University of Rochester School of Medicine and Dentistry in August, 1995.

Dr. Messing has been involved in multiple clinical studies relevant to Imagin's focus. Having both Dr. Messing and Dr. Stavros Demos, the inventor of the i/Blue, at the same institution, is a major advantage that will help drive Imagin's development and clinical trial programs.

"We are excited to have Dr. Messing join our scientific advisory board. He brings a wealth of knowledge about bladder cancer and its treatment, and will provide invaluable insight for us as we move forward," said Jim Hutchens, Imagin's president and chief executive officer.

We seek Safe Harbor.

© 2024 Canjex Publishing Ltd. All rights reserved.